Advertisement
Screener

REGEN BIOPHARMA, INC. (RGBP) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

1.4 / 5 stars · 23/80 Roast Me

REGEN BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

REGEN BIOPHARMA, INC. (RGBP) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum of 273.00% for the 12-month period ending 2020-09-30, per its 10-K filed 2021-08-04.

Discontinued › Notes › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum · last filed 2021-08-05

  • REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2019-12-31 was 273.00%, a 63.58% increase year-over-year.
  • REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2018-12-31 was 166.89%, a 5.63% increase year-over-year.
  • REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2017-12-31 was 158.00%.
  • REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2020 was 273.00%, a 31.81% increase from fiscal 2019.
  • REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2019 was 207.11%, a 25.57% increase from fiscal 2018.
  • REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2018 was 164.93%, a 33.01% increase from fiscal 2017.
  • REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2017 was 124.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 12 month
2020-09-30273.00%
10-K · filed 2021-08-04
2020-06-30273.00%
10-Q · filed 2021-08-05
2020-03-31273.00%
10-Q · filed 2021-08-05
2019-12-31273.00%
10-Q · filed 2021-08-05
2019-09-30207.11%
10-K · filed 2021-06-21
2019-06-30188.87%
10-Q · filed 2019-10-24
2019-03-31168.66%
10-Q · filed 2019-08-29
2018-12-31166.89%
10-Q · filed 2019-02-12
2018-09-30164.93%
10-K · filed 2018-12-27
2017-12-31158.00%
10-Q · filed 2018-02-06
2017-09-30124.00%
10-K · filed 2018-01-05